Barracuda Networks, Inc. designs and delivers security and storage solutions. It offers cloud-connected solutions that help its customers address security threats, enhance network performance, and protect and store their data. The company provides various security solutions, including email security solutions, such as Barracuda Spam Firewall and Barracuda Email Security Service; Barracuda Web Filter, a Web security solution to protect users from rapidly evolving Web-based threats, as well as to enhance productivity and optimize bandwidth; next-generation firewall solutions; Barracuda Web Application Firewall, an application security solution for protecting Web servers from data breaches and downtime; Barracuda Load Balancer ADC that optimizes application performance, availability, and security; Barracuda SSL VPN, which offers remote users with secure access to internal network resources from any Web browser while providing the security needed to protect internal systems from unauthorized access, viruses, and other malware; and Barracuda Security Suite, an integrated network security solution. It also offers storage solutions comprising Barracuda Backup, an end-to-end solution that simplifies the backup process and enables secure offsite replication; Barracuda Message Archiver that reduces archive sizes through eliminating duplicate messages; Copy, a cloud-based file storage platform that allows its customers to securely access, share, and sync files of any size from any device; and CudaSign, a mobile eSignature application. The company sells its appliances, services, and software products to education, government, financial services, healthcare, professional services, telecommunications, retail, and manufacturing industries through its sales personnel, distribution partners, and value added resellers in approximately 100 countries worldwide. Barracuda Networks, Inc. was founded in 2003 and is headquartered in Campbell, California.
Yodlee, Inc. operates a technology and applications platform that provides digital financial services in the cloud. The company's platform, the Yodlee Financial Cloud, delivers a range of financial applications (FinApps) for the retail financial, wealth management, small business, card, and other financial solutions sectors. These FinApps allows consumers and small businesses to simplify and manage their finances, review their financial accounts, track their spending, calculate their net worth, and perform various other activities. The Yodlee Financial Cloud platform also enables its customers to develop their own applications through its open application programming interfaces, which deliver trusted and secure data, money movement solutions, and other feature functionalities. The company also offers data solutions and market research services. It serves financial institutions, as well as Internet service companies providing financial solutions, and third-party developers of financial applications. Yodlee, Inc. was founded in 1999 and is headquartered in Redwood City, California.
EverBank Financial Corp, a savings and loan holding company, provides various financial products and services to individuals and small and mid-size businesses in the United States. It operates in three segments: Consumer Banking, Commercial Banking, and Corporate Services. Its deposit products include noninterest-bearing and interest-bearing demand deposits, savings and money market accounts, and time deposits. The company's loan products portfolio comprises residential mortgage loans, owner-occupied commercial real estate, commercial investment properties, asset-backed commercial, and small business commercial loans; equipment financing receivables; home equity lines; and personal loans, credit card loans and lines of credit, and automobile and other loans. It also provides financial advisory, planning, brokerage, and other wealth management services. EverBank Financial Corp offers its services through online financial portal, independent financial advisors, financial centers, and other financial intermediaries. The company is headquartered in Jacksonville, Florida.
HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. Its products and services include healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. The company also offers online-only investment advisory services through HealthEquity Advisor, a Web-based tool; and healthcare incentives that enable its employer partners and health plan partners to provide, and its members to earn, financial incentives for participation in wellness programs. HealthEquity, Inc. was founded in 2002 and is based in Draper, Utah.
Raptor Pharmaceutical Corp., a biopharmaceutical company, focuses on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases. The company offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults, as well as in six years and older children in the United States, in the 28 member states of the European Union, Norway, Liechtenstein, and Iceland. Its clinical development programs include RP103 that is used as a treatment for Huntington's disease; RP103 as a treatment for non-alcoholic fatty liver disease in children; and RP103 as a treatment for mitochondrial disorders, including Leigh syndrome. The company's other clinical-stage product candidates comprise Convivia, an oral formulation of 4-methylpyrazole for the treatment of acetaldehyde toxicity resulting from aldehyde dehydrogenase deficiency. Its preclinical product candidates include cysteamine dioxygenase and HepTide for the treatment of hepatocellular carcinoma and other cancers susceptible to induced lysosomal storage. Raptor Pharmaceuticals Corp. has a collaboration agreement with DaVita Clinical Research to screen blood samples from the United States patients with end-stage renal disease to identify patients with unrecognized late-onset nephropathic cystinosis. The company was founded in 2005 and is headquartered in Novato, California.
Heritage Commerce Corp operates as the bank holding company for Heritage Bank of Commerce that provides various commercial and personal banking services to residents and the business/professional community in California. It offers a range of deposit products for retail and business banking markets, including checking accounts, interest-bearing transaction accounts, savings accounts, time deposits, and retirement accounts. The company also provides various loan products comprising commercial loans, such as operating secured and unsecured loans advanced for working capital, equipment purchases, and other business purposes; commercial real estate loans; commercial construction loans for rental properties, commercial buildings, and homes; home equity lines of credit; consumer loans consisting of loans for financing automobiles, various consumer goods, and other personal purposes; and small business administration loans. In addition, it offers other banking services, including cashier's checks, traveler's checks, bank-by-mail, ATMs, night depositories, safe deposit boxes, direct deposit, automated payroll, electronic funds transfer, online banking, online bill pay, remote deposit capture, automated clearing house origination, electronic data interchange, and check imaging services, as well as other customary banking services. The company provides its banking products and services through 11 full service branch offices in the southern and eastern regions of the general San Francisco Bay Area of California in the counties of Santa Clara, Alameda, and Contra Costa. Heritage Commerce Corp was founded in 1993 and is based in San Jose, California.
salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. The company offers enterprise cloud computing apps and platform services, including Sales Cloud for sales force automation, which enables companies to store data, access accurate customer and prospect information, track leads and progress, forecast opportunities, and collaborate around any sale on desktop and mobile devices; Service Cloud that enables companies to connect address customers service and support needs; and Marketing Cloud, which enables companies to map customer journeys to digital marketing interactions through email, mobile, social, Web, and connected products. It also provides Community Cloud, a platform to engage specific group of people with access to relevant information, apps, and experts; Analytics Cloud, an app and platform to deploy sales, service, marketing, and custom analytics apps using any data source; Salesforce1 Platform, a cloud platform to build apps that manage various business processes. In addition, the company provides professional services, including consulting, deployment, training, implementation, and integration services to facilitate the adoption of its cloud solutions. It sells and markets its services primarily through its direct sales force, as well as through global consulting firms, systems integrators, and regional partners. salesforce.com, inc. was founded in 1999 and is headquartered in San Francisco, California.
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine. The company's principal products include Neulasta, a pegylated protein to decrease the incidence of infection associated with chemotherapy-induced febrile neutropenia in cancer patients; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor for reducing the incidence of infection as manifested by febrile neutropenia for patients with non-myeloid malignancies; and Enbrel to treat rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis in adult patients. Its principal products also comprise EPOGEN for the treatment of dialysis; Aranesp for treating anemia; XGEVA for the prevention of skeletal-related events; Prolia to treat postmenopausal women with osteoporosis; and Sensipar/Mimpara products for use in the treatment of secondary hyperparathyroidism in chronic kidney disease patients on dialysis. The company's other marketed products include Kyprolis, a proteasome inhibitor to treat patients with multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; Vectibix, a human monoclonal antibody; and BLINCYTO for the treatment of patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. It also develops various products that are in various clinical trials. The company serves pharmaceutical wholesale distributors; and healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. It has collaborative agreements with AstraZeneca Plc; Takeda Pharmaceutical Company Limited; UCB; and Bayer HealthCare Pharmaceuticals Inc. The company was founded in 1980 and is headquartered in Thousand Oaks, California.
Orbital ATK, Inc. designs, builds, and delivers space, defense, and aviation-related systems in the United States and internationally. It operates through three segments: Flight Systems Group, Defense Systems Group, and Space Systems Group. The Flight Systems Group segment develops rockets that are used as small-and medium-class space launch vehicles to place satellites into Earth orbit and escape trajectories; interceptor and target vehicles for missile defense systems; suborbital launch vehicles that place payloads into various high-altitude trajectories; rocket propulsion systems for human and cargo launch vehicles; strategic missiles; missile defense interceptors and target vehicles; composite structures for military and commercial aircraft and launch structures markets; and illuminating flares and aircraft countermeasures. The Defense Systems Group segment develops and produces military ammunition; small-caliber commercial ammunition; precision weapons and munitions; high-performance gun systems; propellant and energetic materials; propulsion systems for tactical missiles and missile defense applications; strike weapons; aircraft survivability systems; fuzes and warheads; special mission aircraft; airborne missile warning systems; defense electronics; and advanced anti-radiation guided missile and multi-stage supersonic target products. The Space Systems Group segment offers small-and medium-class satellites that are used to enable global and regional communications and broadcasting; conduct space-related scientific research; and perform other activities related to national security. This segment also provides human-rated space systems for Earth-orbit and deep-space exploration, including re-supplying the international space station; and spacecraft components and subsystems, as well as specialized engineering and operations services to the United States government agencies. The company is headquartered in Dulles, Virginia.
ViaSat, Inc. provides satellite and wireless networking applications; and secure networking systems, products, and services worldwide. The company's Satellite Services segment offers retail and wholesale broadband satellite services under the Exede and WildBlue brand names, which offers two-way satellite-based broadband Internet access and voice over Internet protocol to consumers and businesses. It also provides mobile broadband services comprising network management and high-speed Internet connectivity services for customers using airborne, maritime, and ground mobile satellite systems; and enterprise broadband services. As of April 3, 2015, this segment provided broadband satellite services to approximately 686,000 subscribers. Its Commercial Networks segment offers fixed satellite networks that comprise satellite network infrastructure and ground terminals designed to access Ka-band broadband services; mobile broadband satellite communication systems; and antenna systems for terrestrial and satellite applications, such as geospatial imagery, mobile satellite communication, Ka-band gateways, and other multi-band antennas. This segment also provides design and technology services, including analysis, design, and specification of satellites and ground systems; ASIC and MMIC design and production; and wide area network compression for enterprise networks. The Company's Government Systems segment offers government satellite communication systems, including various broadband modems, terminals, network access control systems, and antenna systems; information security and assurance products, and secure networking solutions; and tactical radio and information distribution systems to enable real-time collection and dissemination of secure real-time digital information between command centers, communications nodes, and air defense systems. ViaSat, Inc. was founded in 1986 and is headquartered in Carlsbad, California.